Built in 1927, the owner of the cement-covered, wood-frame haunt on South Tacoma Way has slowly but surely been restoring the ...

Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic ...

During National Transfer Student Week, I had the opportunity to present my dissertation findings. I was eager to share insights and connect with others doing similar work. Yet my excitement quickly ...

The Air Force is yanking most of its biggest programs out from its existing program-management structure and putting them under a new four-star who reports to the deputy defense secretary. On Tuesday, ...

While the mortgage industry has applauded the Trump administration’s push to restore a partial claim option for U.S. Department of Veterans Affairs (VA) loans, many experts warn it may arrive too late ...

Strong financial position with cash, cash equivalents and short-term investments of $786.5 million as of June 30, 2025 expected to fund projected operations and key clinical milestones through at ...

Correction: The original version of this article incorrectly stated that the Hands Off Student Initiated Projects campaign is demanding the extension of current project director contracts to January.